Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase IIb study explores use of cytomegalovirus vaccine V-160

May 23, 2018

Kyowa Hakko Kirin launches Orkedia in Japan

May 23, 2018

University of Wollongong presents u-PA inhibitors

May 23, 2018

Sphingosine 1-phosphate receptor 5 agonists identified at AbbVie

May 23, 2018

Roche describes compounds for hepatitis B virus infection

May 23, 2018

Arbutus Biopharma, Protiva Biotherapeutics patent anti-HBV compounds

May 23, 2018

Biguanide derivative shows promise for prostate cancer therapy

May 23, 2018

Monoclonal antibodies shown to protect mice from EBOV infection

May 23, 2018

Cognition Therapeutics awarded NIH grants to further study lead candidate

May 23, 2018

Actavalon discovers anticancer compounds

May 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...